(4) For CCM, general BHI, and Principal Care Management (PCM) services furnished between January 1, 2021, and December 31, 2022, payment is based on the average of the national non-facility PFS payment rate set for each CCM, general BHI, and PCM service and updated annually based on the PFS amounts
CHCl 3 ) 7.76 (2H, d, J=7.5 Hz, FmocH), 7.62 (2H, d, J=7.4 Hz, FmocH), 7.39 (2H, t, J=7.4 Hz, FmocH), 7.30 (2H, td, J=11.2, 0.9 Hz, FmocH), 5.78 (1H, d, J=7.6 Hz, NH), 5.04-4.95 (1H, m, H-4), 4.60 (1H, dd, J=12.2, 5.2 Hz, H-1), 4.38 (2H, d, J=7.2 Hz, FmocCH 2 ), 4.24 (2H, t, J=7.1 Hz, FmocCH), 4.13-3.99 (2H, m, H-7), 3.16 (1H, dd, J=13.9, 4.5 Hz, H-2), 3.04 (1H, dd, J=14.0, 5.3 Hz, H-2), 2.78-2.70 (2H, m, H-3), 2.34-2.25 (4H, m, 2PamCH 2a alkyl), 1.74-1.56 (8H, m, 2PamCH 2 alkyl, H-5, H-6), 1.32-1.22 (48H, m, 24PamCH 2 alkyl), 0.88 (6H, t, J=6.9 Hz, 2PamCH 3 alkyl)
Please refer to the online application posting for REBYOTA TM , available at , for additional detail describing the technology and the disease treated by the technology
[DOI] [PMC free article] [PubMed] [Google Scholar] 57.He B, Yuan X, Zhou A, Zhang H, Jiang D